Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Times change. Therapies once proven beneficial may not remain so forever. I will make the case that we need a redo of the primary prevention ICD trials. First, a brief review of the DANISH trial, then ...

SAN FRANCISCO, CA—A primary prevention implantable cardioverter-defibrillator (ICD) seems to lessen the risk of dying among patients with heart failure and reduced ejection fraction (HFrEF) even on ...

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...

New report in the Canadian Journal of Cardiology shows that rural patients have lower referral rates and higher refusal rates for implantable cardioverter defibrillators, a standard device therapy for ...

Appropriate and inappropriate therapies of implantable cardioverter defibrillators have a major impact on morbidity and quality of life in ICD recipients, but have not been systematically studied in ...

Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...